The Breakthroughs podcast released 17 episodes in 2024, on topics ranging from biological age research to new insights in inflammation and microbiome science, as well as health equity research and community engagement efforts.
Translating medical research findings from the research laboratory into patient care, otherwise known as from “bench to bedside,” is far more complex than it sounds, but is imperative to improve human health.
Distinguished biochemist Ron Evans, PhD, director of the Gene Expression Laboratory and professor at the Salk Institute for Biological Studies, has been named the winner of the annual $250,000 Kimberly Prize in Biochemistry and Molecular Genetics.
Ten Feinberg faculty members were named to the 2024 “Highly Cited Researchers” list, published by Clarivate Analytics.
Feinberg principal investigators secured $742.2 million dollars in research funding and awards during the 2023-24 fiscal year, a five percent increase over the previous year, and the largest amount in the school’s history.
Alan Hauser, MD, PhD, professor and vice chair of Microbiology-Immunology, has been named the winner of the 2024 Tripartite Legacy Faculty Prize in Translational Science and Education.
A map of the Northwestern University Transplant Outcomes Research Collaborative (NUTORC) Network looks like an intricate spiderweb. Hovering over one investigator’s name, you see the many investigators they are connected with through publications and research collaboration.
Dan Foltz, PhD, professor of Biochemistry and Molecular Genetics, has been named director of the Walter S. and Lucienne Driskill Graduate Program in Life Sciences (DGP). He will begin the role on July 1.
Feinberg’s Medical Faculty Council (MFC) honored the recipients of the 2024 Mentor of the Year awards at a workshop on May 29, with awardees sharing insights from their experiences mentoring students, trainees and peers.
As GLP-1 receptor agonist medications like semaglutide have been shown to be effective at helping patients lose weight, scientists are now asking, whether they can treat other conditions where obesity is a risk factor. Most recently, initial studies have shown that they can reduce the risk of cardiovascular disease by reducing overall body weight.